Ratings Premier Health of America Inc.

Equities

PHA

CA74052G1063

Market Closed - Toronto S.E. 09:41:03 2024-07-04 am EDT 5-day change 1st Jan Change
0.36 CAD -5.26% Intraday chart for Premier Health of America Inc. +2.86% -16.28%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 98% by 2026.
  • The company shows low valuation levels, with an enterprise value at 0.39 times its sales.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
-16.28% 15.48M -
-4.43% 253B
B
+2.80% 59.99B
B
-18.30% 59.84B
B-
+1.16% 53.08B
A-
+8.33% 43.99B
C
+1.36% 36.85B
B
+118.22% 28.61B -
-9.90% 28.54B
B
+5.15% 22.03B
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
-
  1. Stock Market
  2. Equities
  3. PHA Stock
  4. Ratings Premier Health of America Inc.